RABEPRAZOLE SODIUM
RABEPRAZOLE SODIUM is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: RABEPRAZOLE SODIUM; Generic name: RABEPRAZOLE SODIUM; Manufacturer: Advanced Rx of Tennessee, LLC.
| Brand name | RABEPRAZOLE SODIUM |
|---|---|
| Generic name | RABEPRAZOLE SODIUM |
| Manufacturer | Advanced Rx of Tennessee, LLC |
| Used for | 1 INDICATIONS AND USAGE Rabeprazole Sodium delayed-release tablets is a proton pump inhibitor (PPI) indicated in adults for: Healing of Erosive or Ulcerative Gastroesophageal Reflux Disease (GERD) ( 1.1 ). Maintenance of Healing of Erosive or Ulcerative GERD ( 1.2 ). Treatment of Symptomatic GERD ( 1.3 ). Healing of Duodenal Ulcers ( 1.4 ). Helicobacter pylori Eradication to Reduce Risk of Duodenal Ulcer Recurrence ( 1.5 ). Treatment of Pathological Hypersecretory Conditions, Including Zollinger-Ellison Syndrome ( 1.6 ). In adolescent patients 12 years of age and older for: Short-term Treatment of Symptomatic GERD ( 1.7 ). 1.1 Healing of Erosive or Ulcerative GERD in Adults Rabeprazole Sodiu |
| Dosage | 2 DOSAGE AND ADMINISTRATION Table 1 shows the recommended dosage of Rabeprazole Sodium delayed-release tablets in adults and adolescent patients 12 years of age and older. The use of Rabeprazole Sodium delayed-release tablets is not recommended for use in pediatric patients 1 year to less than 12 years of age because the lowest available tablet strength (20 mg) exceeds the recommended dose for these patients. Use another rabeprazole formulation for pediatric patients 1 year to less than 12 years |
| Active ingredient(s) | RABEPRAZOLE SODIUM |
| Route | ORAL |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0863f340-4c7e-379a-e063-6394a90a758d |